Lack of innovation in mental health. Need for more efficient communication/collaboration between FDA/DEA and need for VA to operationalize itself for when new therapies are approved by the FDA and rescheduled by the DEA.
2026 · 2nd Quarter (Apr 1 - June 30)
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
Filed by DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.).
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- Not reported
- Expenses
- $90,000.00
- Filing UUID
- 6f2ad41b-70ad-4f03-a889-84aafd8533b0
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.